FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2340489614> ?p ?o ?g. }

• W2340489614 endingPage "29667" @default.
• W2340489614 startingPage "29657" @default.
• W2340489614 abstract "// James L. Bown 1, 2 , Mark Shovman 2, 4 , Paul Robertson 2 , Andrei Boiko 1, 2 , Alexey Goltsov 1 , Peter Mullen 3 , David J. Harrison 3 1 School of Science, Engineering and Technology, Abertay University, Dundee, DD1 1HG, UK 2 School of Arts, Media and Computer Games, Abertay University, Dundee, DD1 1HG, UK 3 School of Medicine, University of St Andrews, St Andrews, KY16 9TF, UK 4 Yahoo Labs, Haifa, 31905, Israel Correspondence to: James L. Bown, email: j.bown@abertay.ac.uk David J. Harrison, email: david.harrison@st-andrews.ac.uk Keywords: interactive visualization, systems biology, signaling networks, combination therapy, biomarker discovery Received: January 25, 2016      Accepted: March 31, 2016      Published: May 18, 2016 ABSTRACT Targeted cancer therapy aims to disrupt aberrant cellular signalling pathways. Biomarkers are surrogates of pathway state, but there is limited success in translating candidate biomarkers to clinical practice due to the intrinsic complexity of pathway networks. Systems biology approaches afford better understanding of complex, dynamical interactions in signalling pathways targeted by anticancer drugs. However, adoption of dynamical modelling by clinicians and biologists is impeded by model inaccessibility. Drawing on computer games technology, we present a novel visualization toolkit, SiViT, that converts systems biology models of cancer cell signalling into interactive simulations that can be used without specialist computational expertise. SiViT allows clinicians and biologists to directly introduce for example loss of function mutations and specific inhibitors. SiViT animates the effects of these introductions on pathway dynamics, suggesting further experiments and assessing candidate biomarker effectiveness. In a systems biology model of Her2 signalling we experimentally validated predictions using SiViT, revealing the dynamics of biomarkers of drug resistance and highlighting the role of pathway crosstalk. No model is ever complete: the iteration of real data and simulation facilitates continued evolution of more accurate, useful models. SiViT will make accessible libraries of models to support preclinical research, combinatorial strategy design and biomarker discovery." @default.
• W2340489614 created "2016-06-24" @default.
• W2340489614 creator A5007079605 @default.
• W2340489614 creator A5009340780 @default.
• W2340489614 creator A5028342003 @default.
• W2340489614 creator A5048104678 @default.
• W2340489614 creator A5048995720 @default.
• W2340489614 creator A5056987393 @default.
• W2340489614 creator A5089893713 @default.
• W2340489614 date "2016-05-18" @default.
• W2340489614 modified "2023-09-25" @default.
• W2340489614 title "A signaling visualization toolkit to support rational design of combination therapies and biomarker discovery: SiViT" @default.
• W2340489614 cites W1535234514 @default.
• W2340489614 cites W1885230615 @default.
• W2340489614 cites W1967469505 @default.
• W2340489614 cites W1978486653 @default.
• W2340489614 cites W1978839489 @default.
• W2340489614 cites W1988099693 @default.
• W2340489614 cites W1988452823 @default.
• W2340489614 cites W1990808537 @default.
• W2340489614 cites W1998203489 @default.
• W2340489614 cites W2007632818 @default.
• W2340489614 cites W2014578307 @default.
• W2340489614 cites W2014810972 @default.
• W2340489614 cites W2037720820 @default.
• W2340489614 cites W2043841986 @default.
• W2340489614 cites W2044085368 @default.
• W2340489614 cites W2052705131 @default.
• W2340489614 cites W2069103780 @default.
• W2340489614 cites W2070102480 @default.
• W2340489614 cites W2099516272 @default.
• W2340489614 cites W2123183032 @default.
• W2340489614 cites W2136760727 @default.
• W2340489614 cites W2137224863 @default.
• W2340489614 cites W2150908245 @default.
• W2340489614 cites W2156216776 @default.
• W2340489614 cites W2158622495 @default.
• W2340489614 cites W4255252731 @default.
• W2340489614 doi "https://doi.org/10.18632/oncotarget.8747" @default.
• W2340489614 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5444693" @default.
• W2340489614 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27302920" @default.
• W2340489614 hasPublicationYear "2016" @default.
• W2340489614 type Work @default.
• W2340489614 sameAs 2340489614 @default.
• W2340489614 citedByCount "2" @default.
• W2340489614 countsByYear W23404896142018 @default.
• W2340489614 countsByYear W23404896142023 @default.
• W2340489614 crossrefType "journal-article" @default.
• W2340489614 hasAuthorship W2340489614A5007079605 @default.
• W2340489614 hasAuthorship W2340489614A5009340780 @default.
• W2340489614 hasAuthorship W2340489614A5028342003 @default.
• W2340489614 hasAuthorship W2340489614A5048104678 @default.
• W2340489614 hasAuthorship W2340489614A5048995720 @default.
• W2340489614 hasAuthorship W2340489614A5056987393 @default.
• W2340489614 hasAuthorship W2340489614A5089893713 @default.
• W2340489614 hasBestOaLocation W23404896141 @default.
• W2340489614 hasConcept C152662350 @default.
• W2340489614 hasConcept C154945302 @default.
• W2340489614 hasConcept C2781197716 @default.
• W2340489614 hasConcept C3018449070 @default.
• W2340489614 hasConcept C36464697 @default.
• W2340489614 hasConcept C41008148 @default.
• W2340489614 hasConcept C54355233 @default.
• W2340489614 hasConcept C60644358 @default.
• W2340489614 hasConcept C62478195 @default.
• W2340489614 hasConcept C70721500 @default.
• W2340489614 hasConcept C86803240 @default.
• W2340489614 hasConceptScore W2340489614C152662350 @default.
• W2340489614 hasConceptScore W2340489614C154945302 @default.
• W2340489614 hasConceptScore W2340489614C2781197716 @default.
• W2340489614 hasConceptScore W2340489614C3018449070 @default.
• W2340489614 hasConceptScore W2340489614C36464697 @default.
• W2340489614 hasConceptScore W2340489614C41008148 @default.
• W2340489614 hasConceptScore W2340489614C54355233 @default.
• W2340489614 hasConceptScore W2340489614C60644358 @default.
• W2340489614 hasConceptScore W2340489614C62478195 @default.
• W2340489614 hasConceptScore W2340489614C70721500 @default.
• W2340489614 hasConceptScore W2340489614C86803240 @default.
• W2340489614 hasIssue "18" @default.
• W2340489614 hasLocation W23404896141 @default.
• W2340489614 hasLocation W23404896142 @default.
• W2340489614 hasLocation W23404896143 @default.
• W2340489614 hasLocation W23404896144 @default.
• W2340489614 hasLocation W23404896145 @default.
• W2340489614 hasLocation W23404896146 @default.
• W2340489614 hasOpenAccess W2340489614 @default.
• W2340489614 hasPrimaryLocation W23404896141 @default.
• W2340489614 hasRelatedWork W1990159977 @default.
• W2340489614 hasRelatedWork W2010715465 @default.
• W2340489614 hasRelatedWork W2019974881 @default.
• W2340489614 hasRelatedWork W2071228812 @default.
• W2340489614 hasRelatedWork W2132914709 @default.
• W2340489614 hasRelatedWork W2612863830 @default.
• W2340489614 hasRelatedWork W2743742842 @default.
• W2340489614 hasRelatedWork W2958553036 @default.
• W2340489614 hasRelatedWork W2996077172 @default.
• W2340489614 hasRelatedWork W4226174374 @default.
• W2340489614 hasVolume "8" @default.

• next